| pubmed-article:14657598 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14657598 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:14657598 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:14657598 | lifeskim:mentions | umls-concept:C0039736 | lld:lifeskim |
| pubmed-article:14657598 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:14657598 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:14657598 | pubmed:dateCreated | 2003-12-5 | lld:pubmed |
| pubmed-article:14657598 | pubmed:abstractText | To analyze the efficacy of oral thalidomide in the treatment of advanced hepatocellular carcinoma (HCC). | lld:pubmed |
| pubmed-article:14657598 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14657598 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14657598 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14657598 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14657598 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14657598 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14657598 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14657598 | pubmed:issn | 0030-2414 | lld:pubmed |
| pubmed-article:14657598 | pubmed:author | pubmed-author:ChungN PNP | lld:pubmed |
| pubmed-article:14657598 | pubmed:author | pubmed-author:LaiMing-YangM... | lld:pubmed |
| pubmed-article:14657598 | pubmed:author | pubmed-author:LeePo-HuangPH | lld:pubmed |
| pubmed-article:14657598 | pubmed:author | pubmed-author:ChengAnn-LiiA... | lld:pubmed |
| pubmed-article:14657598 | pubmed:author | pubmed-author:YangPei-MingP... | lld:pubmed |
| pubmed-article:14657598 | pubmed:author | pubmed-author:ChenChiung-Ni... | lld:pubmed |
| pubmed-article:14657598 | pubmed:author | pubmed-author:ChenLi-TzongL... | lld:pubmed |
| pubmed-article:14657598 | pubmed:author | pubmed-author:WuChen-YaoCY | lld:pubmed |
| pubmed-article:14657598 | pubmed:copyrightInfo | Copyright 2003 S. Karger AG, Basel | lld:pubmed |
| pubmed-article:14657598 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14657598 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:14657598 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14657598 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14657598 | pubmed:pagination | 242-9 | lld:pubmed |
| pubmed-article:14657598 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:meshHeading | pubmed-meshheading:14657598... | lld:pubmed |
| pubmed-article:14657598 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14657598 | pubmed:articleTitle | Low-dose thalidomide treatment for advanced hepatocellular carcinoma. | lld:pubmed |
| pubmed-article:14657598 | pubmed:affiliation | Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, ROC. | lld:pubmed |
| pubmed-article:14657598 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14657598 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14657598 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14657598 | lld:pubmed |
